Global and China Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 01-Sep-2021
No. of pages: 127
Inquire Before Buying

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Market Analysis and Insights: Global Biopharmaceuticals Market

The global Biopharmaceuticals market size is projected to reach US$ 51410 million by 2027, from US$ 29900 million in 2020, at a CAGR of 8.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceuticals market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceuticals market.

Global Biopharmaceuticals Scope and Market Size

Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Monoclonal Antibodies

- Interferon

- Colony-Stimulating Factor

- Erythropoietin

- Insulin

- Vaccines

- Growth Hormones

- Others

Segment by Application

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- Sun

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

- Dong Bao

- Ganlee

- United Laboratories

- SANDOZ (NOVARTIS)

- Teva Pharmaceutical

- Hospira ?Pfizer?

- MYLAN

- Sun pharma

Global and China Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceuticals Market Perspective (2016-2027)
2.2 Biopharmaceuticals Growth Trends by Regions
2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceuticals Industry Dynamic
2.3.1 Biopharmaceuticals Market Trends
2.3.2 Biopharmaceuticals Market Drivers
2.3.3 Biopharmaceuticals Market Challenges
2.3.4 Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Players by Revenue
3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
3.4 Global Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020
3.5 Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Breakdown Data by Type
4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)
5 Biopharmaceuticals Breakdown Data by Application
5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceuticals Market Size (2016-2027)
6.2 North America Biopharmaceuticals Market Size by Type
6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)
6.3 North America Biopharmaceuticals Market Size by Application
6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)
6.4 North America Biopharmaceuticals Market Size by Country
6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceuticals Market Size (2016-2027)
7.2 Europe Biopharmaceuticals Market Size by Type
7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)
7.3 Europe Biopharmaceuticals Market Size by Application
7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)
7.4 Europe Biopharmaceuticals Market Size by Country
7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size (2016-2027)
9.2 Latin America Biopharmaceuticals Market Size by Type
9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceuticals Market Size by Application
9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceuticals Market Size by Country
9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceuticals Introduction
11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceuticals Introduction
11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceuticals Introduction
11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceuticals Introduction
11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceuticals Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceuticals Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceuticals Introduction
11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceuticals Introduction
11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Sun
11.11.1 Sun Company Details
11.11.2 Sun Business Overview
11.11.3 Sun Biopharmaceuticals Introduction
11.11.4 Sun Revenue in Biopharmaceuticals Business (2016-2021)
11.11.5 Sun Recent Development
11.12 3sbio
11.12.1 3sbio Company Details
11.12.2 3sbio Business Overview
11.12.3 3sbio Biopharmaceuticals Introduction
11.12.4 3sbio Revenue in Biopharmaceuticals Business (2016-2021)
11.12.5 3sbio Recent Development
11.13 Changchun High Tech
11.13.1 Changchun High Tech Company Details
11.13.2 Changchun High Tech Business Overview
11.13.3 Changchun High Tech Biopharmaceuticals Introduction
11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021)
11.13.5 Changchun High Tech Recent Development
11.14 CP Guojian
11.14.1 CP Guojian Company Details
11.14.2 CP Guojian Business Overview
11.14.3 CP Guojian Biopharmaceuticals Introduction
11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2016-2021)
11.14.5 CP Guojian Recent Development
11.15 Biotech
11.15.1 Biotech Company Details
11.15.2 Biotech Business Overview
11.15.3 Biotech Biopharmaceuticals Introduction
11.15.4 Biotech Revenue in Biopharmaceuticals Business (2016-2021)
11.15.5 Biotech Recent Development
11.16 Gelgen
11.16.1 Gelgen Company Details
11.16.2 Gelgen Business Overview
11.16.3 Gelgen Biopharmaceuticals Introduction
11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2016-2021)
11.16.5 Gelgen Recent Development
11.17 Innovent
11.17.1 Innovent Company Details
11.17.2 Innovent Business Overview
11.17.3 Innovent Biopharmaceuticals Introduction
11.17.4 Innovent Revenue in Biopharmaceuticals Business (2016-2021)
11.17.5 Innovent Recent Development
11.18 Dong Bao
11.18.1 Dong Bao Company Details
11.18.2 Dong Bao Business Overview
11.18.3 Dong Bao Biopharmaceuticals Introduction
11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2016-2021)
11.18.5 Dong Bao Recent Development
11.18 Ganlee
11.25.1 Ganlee Company Details
11.25.2 Ganlee Business Overview
11.25.3 Ganlee Biopharmaceuticals Introduction
11.25.4 Ganlee Revenue in Biopharmaceuticals Business (2016-2021)
11.25.5 Ganlee Recent Development
11.20 United Laboratories
11.20.1 United Laboratories Company Details
11.20.2 United Laboratories Business Overview
11.20.3 United Laboratories Biopharmaceuticals Introduction
11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2016-2021)
11.20.5 United Laboratories Recent Development
11.21 SANDOZ (NOVARTIS)
11.21.1 SANDOZ (NOVARTIS) Company Details
11.21.2 SANDOZ (NOVARTIS) Business Overview
11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021)
11.21.5 SANDOZ (NOVARTIS) Recent Development
11.22 Teva Pharmaceutical
11.22.1 Teva Pharmaceutical Company Details
11.22.2 Teva Pharmaceutical Business Overview
11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021)
11.22.5 Teva Pharmaceutical Recent Development
11.23 Hospira ?Pfizer?
11.23.1 Hospira ?Pfizer? Company Details
11.23.2 Hospira ?Pfizer? Business Overview
11.23.3 Hospira ?Pfizer? Biopharmaceuticals Introduction
11.23.4 Hospira ?Pfizer? Revenue in Biopharmaceuticals Business (2016-2021)
11.23.5 Hospira ?Pfizer? Recent Development
11.24 MYLAN
11.24.1 MYLAN Company Details
11.24.2 MYLAN Business Overview
11.24.3 MYLAN Biopharmaceuticals Introduction
11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2016-2021)
11.24.5 MYLAN Recent Development
11.25 Sun pharma
11.25.1 Sun pharma Company Details
11.25.2 Sun pharma Business Overview
11.25.3 Sun pharma Biopharmaceuticals Introduction
11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2016-2021)
11.25.5 Sun pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Colony-Stimulating Factor
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Key Players of Others
Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)
Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)
Table 16. Biopharmaceuticals Market Trends
Table 17. Biopharmaceuticals Market Drivers
Table 18. Biopharmaceuticals Market Challenges
Table 19. Biopharmaceuticals Market Restraints
Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)
Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)
Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biopharmaceuticals Product Solution and Service
Table 27. Date of Enter into Biopharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)
Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Biopharmaceuticals Product
Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Biopharmaceuticals Product
Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Biopharmaceuticals Product
Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Sanofi-Aventis Company Details
Table 83. Sanofi-Aventis Business Overview
Table 84. Sanofi-Aventis Biopharmaceuticals Product
Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 86. Sanofi-Aventis Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Biopharmaceuticals Product
Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Biopharmaceuticals Product
Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Novo Nordisk Company Details
Table 98. Novo Nordisk Business Overview
Table 99. Novo Nordisk Biopharmaceuticals Product
Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 101. Novo Nordisk Recent Development
Table 102. Eli Lilly Company Details
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Biopharmaceuticals Product
Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Biopharmaceuticals Product
Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 115. Merck Recent Development
Table 116. Sun Company Details
Table 117. Sun Business Overview
Table 118. Sun Biopharmaceuticals Product
Table 119. Sun Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 120. Sun Recent Development
Table 121. 3sbio Company Details
Table 122. 3sbio Business Overview
Table 123. 3sbio Biopharmaceuticals Product
Table 124. 3sbio Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 125. 3sbio Recent Development
Table 126. Changchun High Tech Company Details
Table 127. Changchun High Tech Business Overview
Table 128. Changchun High Tech Biopharmaceuticals Product
Table 129. Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 130. Changchun High Tech Recent Development
Table 131. CP Guojian Company Details
Table 132. CP Guojian Business Overview
Table 133. CP Guojian Biopharmaceuticals Product
Table 134. CP Guojian Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 135. CP Guojian Recent Development
Table 136. Biotech Company Details
Table 137. Biotech Business Overview
Table 138. Biotech Biopharmaceuticals Product
Table 139. Biotech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 140. Biotech Recent Development
Table 141. Gelgen Company Details
Table 142. Gelgen Business Overview
Table 143. Gelgen Biopharmaceuticals Product
Table 144. Gelgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 145. Gelgen Recent Development
Table 146. Innovent Company Details
Table 147. Innovent Business Overview
Table 148. Innovent Biopharmaceuticals Product
Table 149. Innovent Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 150. Innovent Recent Development
Table 151. Dong Bao Company Details
Table 152. Dong Bao Business Overview
Table 153. Dong Bao Biopharmaceuticals Product
Table 154. Dong Bao Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 155. Dong Bao Recent Development
Table 156. Ganlee Company Details
Table 157. Ganlee Business Overview
Table 158. Ganlee Biopharmaceuticals Product
Table 159. Ganlee Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 160. Ganlee Recent Development
Table 161. United Laboratories Company Details
Table 162. United Laboratories Business Overview
Table 163. United Laboratories Biopharmaceuticals Product
Table 164. United Laboratories Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 165. United Laboratories Recent Development
Table 166. SANDOZ (NOVARTIS) Company Details
Table 167. SANDOZ (NOVARTIS) Business Overview
Table 168. SANDOZ (NOVARTIS) Biopharmaceuticals Product
Table 169. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 170. SANDOZ (NOVARTIS) Recent Development
Table 171. Teva Pharmaceutical Company Details
Table 172. Teva Pharmaceutical Business Overview
Table 173. Teva Pharmaceutical Biopharmaceuticals Product
Table 174. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 175. Teva Pharmaceutical Recent Development
Table 176. Hospira ?Pfizer? Company Details
Table 177. Hospira ?Pfizer? Business Overview
Table 178. Hospira ?Pfizer? Biopharmaceuticals Product
Table 179. Hospira ?Pfizer? Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 180. Hospira ?Pfizer? Recent Development
Table 181. MYLAN Company Details
Table 182. MYLAN Business Overview
Table 183. MYLAN BiopharmaceuticalsProduct
Table 184. MYLAN Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 185. MYLAN Recent Development
Table 186. Sun pharma Company Details
Table 187. Sun pharma Business Overview
Table 188. Sun pharma Biopharmaceuticals Product
Table 189. Sun pharma Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 190. Sun pharma Recent Development
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Colony-Stimulating Factor Features
Figure 5. Erythropoietin Features
Figure 6. Insulin Features
Figure 7. Vaccines Features
Figure 8. Growth Hormones Features
Figure 9. Others Features
Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027
Figure 11. Tumor Case Studies
Figure 12. Diabetes Case Studies
Figure 13. Cardiovascular Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Biopharmaceuticals Report Years Considered
Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027
Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)
Figure 21. Global Biopharmaceuticals Market Share by Players in 2020
Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020
Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)
Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)
Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)
Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)
Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)
Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)
Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)
Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)
Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)
Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)
Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)
Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East
  • Global Biopharmaceuticals Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 08-Oct-2021        Price: US 3480 Onwards        Pages: 110
    The Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • Global and China Bio-pharma Market Insights, Forecast to 2027
    Published: 20-Sep-2021        Price: US 3900 Onwards        Pages: 143
    Bio-pharma market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bio-pharma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Bio-pharma market size by players, ......
  • United States Biopharmaceuticals Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 110
    United States Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%) - Monoclonal Antibodies - Interferon - Colony-Stimulating Factor - Erythropoietin - Insulin - Vaccines - Growth Hormones - Others United States Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceutical......
  • Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Calcium Suppliment market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Calcium Suppliment industry, providing statistical information about market dynamics, growth factors......
  • Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Advanced Wound Dressing market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Advanced Wound Dressing industry, providing statistical information about market dynamics,......
  • Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 107
    The Cefotaxime Sodium API market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Cefotaxime Sodium API industry, providing statistical information about market dynamics, growt......
  • Global Empty Hard Gelatin Capsules Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 98
    Gelatin is considered to be animal proteins that are utilized to prepare capsules, which gives calculated quantities of products. Empty hard gelatin capsules are made from gelatin (Gelatin is a translucent, colorless, brittle (when dry), flavorless solid substance, derived from the collagen- an animal protein). Empty Hard Gelatin Capsules contain 12 - 16% moisture. But the moisture content can vary up on the storage conditions. The Empty Hard Gelatin Capsules market revenue was xx Million......
  • Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 117
    The Phytotherapics market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Phytotherapics industry, providing statistical information about market dynamics, growth factors, major chal......
  • Global P2X7 Receptor Antagonists Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 122
    The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells. P2X7 activation results in a number of downstream events, including the release of proinflammatory mediators and cell death and proliferation. The P2X7 Receptor Antagonists market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global P2X7 Receptor Antagonists Market Develop......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs